Tower Research Capital »

Mira Pharmaceuticals shares owned by Tower Research Capital

Quarter-by-quarter ownership of Mira Pharmaceuticals (MIRA) shares owned by Tower Research Capital from 13F filings

Historical chart of Tower Research Capital investment in Mira Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Mira Pharmaceuticals held by Tower Research Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Mira Pharmaceuticals by Tower Research Capital

Quarter filed Position value Share count Share price at filing
2024-12-31 $7.9k 6.9k 1.14

More positions owned by Tower Research Capital

Apple (AAPL)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Tesla Motors (TSLA)
Alphabet Cap Stk Cl C (GOOG)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Spdr Dow Jones Indl Average Ut Ser 1 (DIA)
Select Sector Spdr Tr Sbi Healthcare (XLV)
JPMorgan Chase & Co. (JPM)
Netflix (NFLX)

View all positions for Tower Research Capital

Top funds holding Mira Pharmaceuticals

Cross Staff Investments
Geode Capital Management
Vanguard Group
Citadel Advisors
Virtu Financial
State Street Corporation
Renaissance Technologies
Northern Trust
JustInvest
International Assets Investment Management
Two Sigma Investments
Suncoast Equity Management
First American Bank
Transce3nd
Praetorian Wealth Management

View all funds holding Mira Pharmaceuticals